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1. Introduction  
Pain is a widely spread symptom and one of the most common causes making people seek 
medical attention. Though at present, different methods of pain control such as general 
narcosis, acupuncture, hypnosis, electroanaesthesia, homeopathy, etc., are known, nothing 
is better for safety and reliability than local anaesthesia. More often it is an effective 
alternative to general narcosis and promotes decreasing and even eliminating the use of 
narcotic analgesics in surgery. Dentists, dermatologists and other medical professionals 
apply it in their work. Unfortunately, an "ideal" local anesthetic has not been created yet, 
and all current medicines of the given pharmacological group have some drawbacks. The 
most serious disadvantages are high neuro- and cardiotoxicity, as well as tendency to cause 
allergy. Thus, the search for new, more effective and safe local anesthetics is ongoing and 
scientists all over the world continue to work on this problem. 
Quinolines are the interesting compounds for research in this area. Numerous derivatives of 
this azaheterocycle are widely distributed in nature. Some of them are well-known to man and 
used for curative purposes from ancient times. For example, alkaloids cinchonine (1a, R = ǻ) 
and quinine (1b, R = ǼǺе, Figure 1) with antimalarial properties are isolated from Cinchona L. 
The utility of the majority of other natural quinolines prospects are to be determined. However, 
recently there has been a noticeable progress toward a solution of this problem. Natural 
compounds themselves more often attract the attention of scientists working in different fields 
of science and engineering. The stimulating motive for their research is the widely spread 
conviction that the living nature does nothing without purpose and everything it synthesizes is 
important at all events for life and, therefore, for man (Bochkov & Smith, 1987). This conviction 
finds the experimental confirmation constantly, as a result, at present the spectrum of biological 
properties of natural quinolines has expanded significantly (Kartsev, 2007). 
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Fig. 1. Natural antimalarial drugs and the first synthetic local anesthetic of the quinoline group 
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Hence the increased interest in quinolines by synthetic chemists becomes clear. Their 
belonging to natural metabolites, as well as practically unlimited possibilities for chemical 
transformations make this molecular system, especially its hydroxyanalogues, rather 
convenient matrices for fixing various structural elements-pharmacophores on them. It allows 
making systematic changes into the structure of the finished products and thus to purposefully 
change their physical and chemical, as well as biological properties. Finally one can succeed in 
obtaining new substances corresponding to high requirements for medicines. So, in particular, 
the first local anesthetic of the quinoline group – Cinchocaine (2, Figure 1) was synthesized; 
though it was created 85 ago (Kleemann & Engel, 2001), it has been applied successfully in 
medical practice nowadays (Tomoda et al., 2009; Kang & Shin, 2010; Douglas et al., 2011). 
2. 1-R-4-Hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxamides as a source of 
new privileged structures with the local anesthetics activity  
When systematically studying the biological properties of 1-R-4-hydroxy-2-oxo-1,2-dihydro-
quinoline-3-carboxamides we repeatedly noted the opportunity of creating new potential 
medicines with various effects on a living organism on their basis, including local 
anesthetics (Ukrainets, 1992; Ukrainets et al., 1994). After the experimental study of 
anaesthetic properties of a large group of compounds of this chemical range, our attention 
was paid to the most active of them. Hydrochlorides of (2-diethylaminoethyl)amides of 1-
ethyl- (3a, R = Et) and, especially, 1-propyl- (3b, R = Pr) substituted 4-hydroxy-2-oxo-1,2-
dihydroquinoline-3-carboxylic acids (Figure 2), were superior the known local anesthetic 
Lidocaine by the specific activity possessing at the same time the lower toxicity. 
Later (Gorokhova, 1993) in the same range one more compound – hydrochloride of 1-ethyl-4-
hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxylic acid (2-morpholin-4-ylethyl)amide (4) was 
found. By the level of infiltration anaesthesia this amide had some more activity than its 1-N-
ethyl analogue 3a, but it was noticeably inferior to 1-N-propyl derivative 3b. However, after 
the primary screening it was also included into the list of candidates for profound research as 
it possessed another important for future medicine property – a relatively low toxicity. By this 
parameter amide 4 prevailed over its acyclic analogues 3a,b by a factor of almost 2. 
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Fig. 2. Biologically active 4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxamides 
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And recently (Davidenko, 2011) a new pharmacological property – the ability to block opioid 
receptors – has been revealed in 4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxamides. It 
has also been found that substances closely related in structure can reveal quite opposite 
biological effects. Hydrochloride of 1-allyl-4-hydroxy-6,7-dimethoxy-2-oxo-1,2-dihydro-
quinoline-3-carboxylic acid (3-morpholin-4-ylpropyl)amide (5) in the dose of 1 mg/kg 
completely eliminates the analgesic effect of Tramadol and its homologue – (2-morpholin-4-
yl-ethyl)amide 6 – prolongs the analgesic effect significantly. This fact requires further 
research and is doubtless of interest for researchers engaged in searching not only new 
opioid receptors antagonists, but highly effective pain-killers as well. 
3. Chemical modification of Сhinoxicaine by its transformation into pro-drugs 
All compounds that passed the stage of primary pharmacological screening were subjected 
to more profound and thorough analysis in pre-clinical trials. To evaluate the local 
anaesthetic properties a greater number of parameters were taken into account; these 
parameters characterized the main specific manifestations of the biological effect: potency of 
local anaesthesia, the rate of its onset and duration. Additionally at this stage some 
experimental models, such as repeated infiltration and additional conduction anaesthesia, 
epidural and surface anaesthesia, were involved. The local irritant properties of the 
compounds,  as well as their acute and chronic toxicity were studied.  
From the experiments, only one compound emerged – hydrochloride of 4-hydroxy-2-oxo-1-
propyl-1,2-dihydroquinoline-3-carboxylic acid (2-diethylaminoethyl)amide (3b), which 
further was studied as a privileged structure under the name of Chinoxicaine and was 
transferred to the next level of investigations. This amide causes a rapid, deep and long local 
anaesthesia on all models studied and has a low toxicity. It has been found that prolonged 
introduction of Chinoxicaine to the experimental animals does not produce any statistically 
significant changes in the activity of central nervous  and cardio-vascular systems and does 
not cause negative reactions of the liver and gastrointestinal tract. The medicine does not 
produce nephrotoxic action and, thus, it can be used safely by the patients with renal 
pathology. While using Chinoxicaine, there were no cases of blood pressure decrease, which 
is its beneficial advantage over many known anesthetics. Additional advantages of 
Chinoxicaine are that together with the high specific activity it shows clear antiarrhythmic, 
antimicrobial, antioxidant, and fungicidal effects.  
Simultaneously with the pharmacological studies, diversified synthetic research to find the 
most available method for obtaining Chinoxicaine substance was carried out. As the result, 
principally different synthetic schemes providing a high quality of the final product have 
been suggested (Ukrainets et al., 1998; Ukrayinecz & Bezuhliy, 2002; Romanov & Ukrainets, 
2006). 
Unfortunately, the "Chinoxicaine" project faced some problems. For example, possessing a 
unique set of pharmacological properties Chinoxicaine appeared to be surprisingly poorly 
soluble in water. Its solubility is only 13.85 g in 100 ml of water at 20°С, and this caused 
great difficulty when preparing a stable medicinal form for injections. We solved this 
problem rather rapidly, though water had to be replaced by the combined solvent.  
At the later stages of introduction of a new local anesthetic into medical practice, namely at 
the stage of clinical trials, one more serious drawback was revealed. In some patients, 
Chinoxicaine solution in the site of injection caused a transient feeling of burning. Though 
this undesirable effect lasted less than one minute, further work with the medicine 
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practically lost any progress without its removal. Theoretically a  rather simple and effective 
solution of the problem has been found. The irritant action of Chinoxicaine is completely 
eliminated by addition such substances as adrenaline in insignificant concentrations in its 
solution.  
However, we tried to solve the problem by structure modification well known in the art to 
modern researchers (Kubinyi, 2006).  
For example, on the basis of structural biological regularities previously revealed a quite 
new analogue of Chinoxicaine with the improved properties can be synthesized. But is 
should be taken into account that in such case all complex of biological and pharmaceutical 
trials have to be carried out in a full volume. Besides to achieve the aim is quite unreal as a 
result of synthesis of only one new substance. Most likely, to solve the task successfully is 
possible only after the study of the series of new compounds. 
Taking this into account we began to improve pharmaceutical properties of Chinoxicaine 
from the most rational variant – creation of pro-drugs on its basis. Biologically active source 
in this approach remains the same, that is why both the terms of development and costs for 
its implementation are greatly reduced.  
However, the practical realization of the method is linked with certain difficulties. In 
particular, to increase the water solubility, as a rule, it is necessary to introduce additional 
ionizing groups into the structure of the modified compounds, while to eliminate the irritant 
action the same ionizing groups in the molecule should be masked (Kuznetsov et al., 1991). 
In other words, theoretically possible methods of elimination of the revealed drawbacks of 
Chinoxicaine mutually exclude each other. 
Most likely the irritant action of Chinoxicaine is related to the presence of 4-Ǽǻ-group in its 
structure, which accounts for the marked acid properties in 1-R-4-hydroxy-2-oxo-1,2-
dihydroquinoline-3-carboxamides (Ukrainets, 1988). However, it has been noted 
(Gorokhova, 1993) that the potency of the given side effect to a great extent depends on the 
structure of the amide fragment as well. For example, hydrochloride of 4-hydroxy-2-oxo-1-
propyl-1,2-dihydroquinoline-3-carboxylic acid (2-morpholin-4-ylethyl)amide (7, Figure 3) 
and its 1-N-ethyl analogue 4 mentioned above do not yield to Chinoxicaine in the specific 
activity, but they do not practically render the irritant action. This fact was the foundation 
for performing bioreversible chemical modification of Chinoxicaine by the tertiary amino 
group (Ukrainets et al., 2009). 
One of the obvious solutions of the target trasformation of the Chinoxicaine molecule is 
trasformation into quaternary ammonium salts, which is simple in its performance. It 
should be noted here that common alkyl halides are not suitable for such transformation 
since they form with the medicine – tertiary amine – the stable compounds, which are 
almost not subjected to metabolism and are excreted from the organism unchanged 
(Kuznetsov et al., 1991). Carboxylic acid haloalkyl esters are more interesting. They allow to 
transform tertiary amines in quaternary ammonium salts with labile grouping N+−C−O, 
which is capable of relatively easily to be splitted by hydrolysis and release the initial 
medicine in the form of the corresponding hydrohalide (Kuznetsov et al., 1991; Vinogradova 
et al., 1980). One of this reagents is commercially available bromomethylacetate, by its 
interaction with (2-diethylaminoethyl)amide of 4-hydroxy-2-oxo-1-propyl-1,2-dihydro-
quinoline-3-carboxylic acid (8) in the anhydrous acetonitrile medium the target bromo-
acetoxymethylate 9 was obtained (Figure 3). 
The biological screening has demonstrated that quaternization conducted eliminated the 
irritant action of Chinoxicaine almost completely, unlike it bromoacetoxy-methylate 9 in the 
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form of 2% aqueous solution which causes only insignificant hyperemia of conjunctiva of 
the rabbit’s eye. At the same time in spite of expectations, dissolution in water decreased 
significantly (up to 8.86 g per 100 ml), but usually it increases sharply in pro-drugs of this 
type in 1-2 thresholds comparing to hydrohalides (Vinogradova et al., 1980). Significantly 
there is almost a threefold shortening of the duration of the surface anesthesia by the 
bromoacetoxymethylate 9 and this is evidently due to the low rate of liberation of the 
starting tertiary amine. 
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Fig. 3. Modification of  Chinoxicaine into pro-drugs 
The attempt to optimize the value by substitution of 2-bromomethyl acetate with 2-bromo-
ethyl failed. Under the action of amide 8 the reagent is dehydrobrominated, as a result, 
instead of bromoacetoxyethylate hydrobromide 10 was isolated, it could be also obtained by 
neutralization of the tertiary amino group of amide 8 by hydrobromic acid. Though salt 
formation is not accompanied with the change of number, character and location of covalent 
bonds, it is widely used as an individual type of chemical modification of medicinal 
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substances in medical chemistry. Hence, hydrobromide 10 can be considered as an original 
pro-drug of Chinoxicaine. However, there was no positive results due to transfer of 
hydrochloride to hydrobromide. Absolutely all the parameters worsened: solubility 
decreased to 3.40 g in 100 ml of water, the irritant action increased considerably, and the 
local anaesthetic activity decreased. 
The substitution of hydrogen chloride as a salt-forming reagent of methanesulfonic acid, 
which forms methanesulfonate 11 practically with the quantitative yield reacting with 
amide 8 in the anhydrous diethyl ester medium, was more successful.  
According to the X-ray structural data, in the symmetrically independent part of the unit cell 
of the methanesulfonate 11 there is a molecule of the 4-hydroxy-2-oxo-1-propyl-1,2-
dihydroquinoline-3-carboxylic acid (2-diethylaminoethyl)amide protonated at atom N(19) 
and the methanesulfonic acid anion (see Figure 4).  
The dihydroquinolone fragment is planar within 0.02 Å. The deviations of atoms C(11) and 
C(15) from the mean square plane of the dihydropyridine ring are 0.067 and 0.022 Å 
respectively. A marked deviation of atom C(11) from the ring plane is explained by the 
presence of a shortened intramolecular contact H(9)···H(11B) of 1.986 Å. The amide fragment 
is virtually coplanar with the dihydroquinolone (torsional angle C(4)–C(3)–C(15)–O(15) = 4º). 
Such an orientation is stabilized by two intramolecular hydrogen bonds: O(4)–H(4)···O(15) 
(H···O 1.74 Å, O–H···O 155º) and N(16)–H(16)···O(2) (H···N 1.91 Å, N···H–O 140º). 
The O(4)–C(4) 1.319(3), N(16)–C(15) 1.313(3), and C(2)–C(3) 1.451(3) Å bonds in the compound 
studied are shortened (mean values 1.331, 1.334, and 1.464 Å respectively) but the O(15)–C(15) 
1.264(3) and C(3)–C(4) 1.379(3) Å bonds are lengthened (mean values 1.231 and 1.363 Å 
respectively). 
 
 
Fig. 4. The structure of the methanesulfonate 11 molecule with atomic numbering. The 
dotted lines indicate the intra-  and intermolecular hydrogen bonds 
Atom N(1) has a planar trigonal configuration. The substituents at atoms N(1) and N(16) have 
an anti-periplanar conformation (torsional angles N(1)–C(11)–C(12)–C(13) and N(16)–C(17)–C(18)–
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N(19) 176.2 and 176.3º respectively). The plane of the carbon atoms of the propyl group on the 
N(1) atom is virtually perpendicular to the mean-square plane of the dihydropyridine ring, 
the angle between them being 89.1º. 
In the crystal the molecules of the methanesulfonate 11 form dimers via stacking interactions 
between the dihydroquinolone fragments, the benzene rings being situated over the 
dihydropyridines. The distance between the ring centroids is 3.54 Å and the mean-square 
planes of the dihydropyridine and benzene fragments form a dihedral angle of 2.2º. 
The cation and anion are mutually bonded by an intermolecular hydrogen bond N(19)–
H(19)···O(11) (H···O 1.88 Å, N–H···O 176º). 
The biological screening has shown that methanesulfonate 11 demonstrates a significant 
improvement of all pharmaceutical properties comparing to the initial hydrochloride 3b 
(Chinoxicaine). In particular, the local irritant action was successfully decreased to the level 
of bromoacetoxymethylate 9. Dissolution in water increased in more than six times – up to 
85.72 g per 100 ml, and it has eliminated the problem of choosing a solvent for preparation 
of a stable medicinal form for injections. Finally, there are also some positive aspects of 
revealing the specific activity: the rate of anaesthesia onset remains the same, but the total 
duration of the surface anaesthesia and the deep anaesthetization phase increased. 
4. Synthesis of conformation stable forms of quinolones as an attempt to 
improve pharmaceutical properties of Сhinoxicaine 
In modern medical chemistry several standard methods are successfully applied for 
improving the privileged structures chosen according to the results of preliminary 
pharmacological trials. Recently with accumulation of information about the spatial 
structure of active binding sites for many types of receptors a greater attention has been 
paid to methodology of conformation restrictions (Chen et al., 2010; Watanabe et al., 2010; 
Nirogia et al., 2011). In general, this method of the structural transformation of a molecule 
suggests the preservation of all functional groups contacting with a biological target in their 
original form and at the same time it is directed to fixing of some of them in ”active” 
conformation. 
One of the most wide-spread ways of practical realization of the method is cyclization, 
which allows transformation of the open side chains of the initial molecule in endo- or exo-
cyclic fragments, making possible the change of the pharmaceutical and (or) 
pharmacokinetic properties. Taking into account the given data it is quite logical to study N-
R-amides of 1-hydroxy-3-oxo-5,6-dihydro-3H-pyrrolo- (12a-m) and 1-hydroxy-3-oxo-6,7-
dihydro-3H,5H-pyrido- (13a-m) [3,2,1-ij]quinoline-2-carboxylic acids as potential local 
anesthetics (Figure 5). 
The interest of these compounds is caused by the fact that they are very similar to 
Chinoxicaine (3b) and its 1-N-ethyl analogue 3a by their structure. At the same time 
amides 12-13a-m have a principally important structural difference: though their 1-N-
alkyl substituents contain the same two-three carbon atoms, they are situated not in the 
open alkyl chains, but are included in the composition of pyrrole or tetrahydropyridine 
cycles annelation with the quinolone nucleus. Such modification is known to lead to the 
essential spatial trasformation of the molecule. In particular, in 1-propylsubstituted 4-
hydroxy-quinolones-2 the ethyl fragment is placed perpendicular the plane of the 
quinolone nucleus, as a result the terminal methyl group is far from the bicycle more than 
3 Å (Ukrainets et al., 2009). And on the contrary, the tricyclic pyrido[3,2,1-ij]quinoline 
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system is much compact – in spite of the sofa conformation of the tetrahydropyridine ring, 
С(6) atom deviates from its relative plane only in 0.56 Å (Ukrainets et al., 2008). Unlike 1-
N-ethylsubstituted 4-hydroxyquinolones-2, in which the methyl group of ethyl 
substituent is never located in the quinolone cycle plane (Baumer et al., 2004; Ukrainets et 
al., 2007), tricyclic pyrrolo[3,2,1-ij]- quinoline system is practically flat (Ukrainets et al., 
2006a). It is clear that transfer from 1-N-ethyl- and 1-N-propylsubtituted 3a,b to 
conformation limited pyrrolo- and pyridoquinolines 12-13 should be obligatory reflected 
to the biological properties. The answer to the question about this influence has been 
found in one of the recent investigations (Kravtsova, 2011).  
 
O
OH O
NH-R
NO
OH O
NH-R
N
13a-m
HCl.
12a-m
HCl.
12-13:   a R =  2-aminoethyl;   b  R  = 3-aminopropyl;  c  R =  4-aminobutyl;  d  R =  6-aminohexyl;
             e R = 2-ethylaminoethyl; f R =  2-(2-hydroxyethylamino)ethyl; g R =  2-dimetylaminoethyl;
             h R = 2-diethylaminoethyl;  i  R =  3-dimethylaminopropyl;   j  R =   3-diethylaminopropyl;
             k R = 2-piperazin-1-ylethyl;  l  R = 2-morpholin-4-ylethyl;  m  R = 3-morpholin-4-ylpropyl
                  
Fig. 5. Tricyclic analogues of Chinoxicaine 
Testing of the samples synthesized has been carried out on the infiltration anaesthesia 
model by Buelbring-Yueid method (Table 1).  
Analysis of the experimental data obtained demonstrates that compounds with the primary 
amino groups, i.e. amides 12-13а-d, do not practically show the anesthetic properties. The 
weak activity (the anaesthesia lasts for not more 5 min, and the phase of complete sensitivity 
loss has not come) has appeared in monoalkylaminoalkylamides 12-13е,f. And only when 
the second alkyl residue is introduced into the terminal amino group (amides 12-13g-m), the 
local anaesthetic action increases noticeably, but though in this case its duration remains 
rather short. For example, for the most active diethylaminoethyl derivative 13h this index is 
approximately 40 min, though the infiltration anaesthesia index reaches the maximum 
possible value. As compared, Chinoxicaine in the similar conditions causes total anaesthesia 
lasting for approximately 75 min (with the general duration of anaesthesia of 4 hours), and 
its 1-N-ethyl analogue 3a – approximately 60 min (with the general duration of anaesthesia 
of 2 hours). 
It is interesting to note that the irritant action of 2% aqueous solutions of tricyclic amides 
12-13, determined by the rabbit’s eye cornea according to the simplified modification of 
Setnikar method, is absent in most examples at all or decreases significantly comparing to 
its bicyclic prototypes 3a,b. And it is in spite of the fact that acidity of enolic Ǽǻ-groups 
in 1-hydroxy-3-oxo-5,6-dihydro-3H-pyrrolo[3,2,1-ij]quinoline-2-carboxylic acid and its  
1-N-ethyl analogue is practically the same, and in 1-hydroxy-3-oxo-6,7-dihydro-3H,5H-
pyrido[3,2,1-ij]-quinoline-2-carboxylic acid is similar with its 1-N-propyl analogue  
(pKaOH = 13,44-13,48). 
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In general, based on the biological trials conducted, it can be stated that the structural 
transformation of the molecule, which accompanies the transfer from 1-alkylsubstitued 4-
hydroxyquinolin-2-ones to conformation limited tricyclic pyrrolo- or tetrahydropyrido-
quinolones, allows to decrease the irritant action of compounds of this class, but at the same 
time it has a strong negative effect on the local anesthetic properties and that is why it can 
be considered as unperspective. 
 
 
Compound 
Infiltration anaesthesia 
Irritative effect, 
points 
The start of 
anaesthesia, 
min 
Index Duration of  total  anaesthesia, min 
12а 4.32 ± 0.28 1.1 Undetermined 0 
12b 3.81 ± 0.21 2.7 Undetermined 0 
12c 4.60 ± 0.33 2.0 Undetermined 0 
12d 4.93 ± 0.39 1.2 Undetermined 0 
12e 3.27 ± 0.30 5.1 Undetermined 0 
12f 3.66 ± 0.27 3.5 Undetermined 0 
12g 2.82 ± 0.31 12.2 10.64 ± 1.20 2 
12h 2.05 ± 0.17 36.0 39.82 ± 2.37 1 
12i 3.09 ± 0.28 9.8 9.27 ± 1.33 2 
12j 2.91 ± 0.32 14.2 15.92 ± 1.24 1 
12k 3.87 ± 0.45 6.4 5.30 ± 1.45 1 
12l 2.24 ± 0.26 27.0 25.56 ± 1.62 0 
12m 3.04 ± 0.34 16.2 14.75 ± 1.18 0 
13а 5.26 ± 0.44 2.8 Undetermined 0 
13b 4.32 ± 0.35 3.9 Undetermined 0 
13c 4.63 ± 0.41 4.2 Undetermined 0 
13d 5.65 ± 0.48 2.3 Undetermined 0 
13e 3.72 ± 0.33 7.6 Undetermined 0 
13f 4.08 ± 0.29 5.4 Undetermined 0 
13g 3.26 ± 0.30 16.7 13.51 ± 1.81 1 
13h 2.23 ± 0.23 36.0 40.24 ± 3.06 1 
13i 3.92 ± 0.22 14.1 8.83 ± 1.26 1 
13j 3.10 ± 0.25 17.3 11.48 ± 2.55 1 
13k 4.05 ± 0.36 9.7 6.63 ± 1.14 0 
13l 2.64 ± 0.23 21.4 28.96 ± 3.73 0 
13m 3.22 ± 0.31 15.8 15.37 ± 2.02 0 
3a 1.84 ± 0.10 36.0 58.92 ± 4.11 2 
Сhinoxicaine 1.61 ± 0.13 36.0 74.79 ± 4.71 2 
Table 1. Biological properties of tricyclic compounds 12-13 
5. Application of the bioisosteric replacements methodology for optimization 
of the Сhinoxicaine molecule 
The term „isosters“ was introduced by Irwing Langmuir at the beginning of the 20th 
century. By his definition, isosters are molecules or ions containing the same number of 
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atoms, as well as the same number and arrangement of electrons. Therefore, “isosteric 
replacements” in the created drugs are replacement of an atom or the group to the similar 
one by size or valency. If the physiological activity remains at the same time, then such 
replacement is called “bioisosteric“. After a while the term “bioisoster“ has been referred to 
compounds obtained by replacement of quite “unsimilar” groupings, but with preserving 
their biological properties (King, 2002). As a result, the concept of bioisosteric replacements 
at present has become one of the most powerful means for creating effective and safe 
medicines (Devereux & Popelier, 2010; Wassermann & Bajorath, 2011; Large et al., 2011). Its 
application allows not only to optimise the known biologically active substances, but to 
reveal new structures with the similar or related properties and, thus, to increase the patent 
protection of a future medicine. 
5.1 Hydrochlorides of 4-hydroxy-2-oxo-1,2,5,6,7,8-hexahydroquinoline-3-carboxylic 
acids N-R-amides 
The first attempt to optimize the Chinoxicaine molecule by the method of bioisosteric 
replacements was replacement of its 1,2-dihydroquinoline nucleus by 1,2,5,6,7,8-hexahydro-
quinoline. We did it expecting that such transformation may appear to be bioisosteric. With 
this aim a large group of hydrochlorides of 4-hydroxy-2-oxo-1,2,5,6,7,8-hexahydro-
quinoline-3-carboxylic acids N-R-amides 14a-y has been synthesized by the method 
developed earlier (Kolisnyk, 2009) (Figure 6).  
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14:     R' = H: a R =  2-aminoethyl;   b  R  = 3-aminopropyl;  c  R =  4-aminobutyl;  d  R =  6-aminohexyl;
                       e R = 2-ethylaminoethyl; f R =  2-(2-hydroxyethylamino)ethyl; g R =  2-dimetylaminoethyl;
                       h R = 2-diethylaminoethyl;  i  R =  3-dimethylaminopropyl;   j  R =   3-diethylaminopropyl;
                       k R = 1-ethylpyrrolidin-2-ylmethyl;  l  R = 2-morpholin-4-ylethyl;  m  R = 3-morpholin-4-
                       ylpropyl;  o R = 3-piperidin-1-ylpropyl;  p R = 3-(4-methylpiperazin-1-yl)propyl; 
                       q R = 4-diethylamino-1-methylbutyl
        R' = Pr:   r R = 2-diethylaminoethyl; s R = 3-diethylaminopropyl
 R' = cyclo-Pr: t R = 2-ethylaminoethyl; u R = 2-(2-hydroxyethylamino)ethyl;  v R =  2-dimetylaminoethyl;
                        w R = 2-diethylaminoethyl; x R = 3-dimethylaminopropyl;   y  R =   3-diethylaminopropyl
14a-y
HCl.
 
Fig. 6. Hydrogenated analogues of Chinoxicaine 
The biological screening conducted allow to state that reduction of the benzene part of the 
quinolone ring, unfortunately, leads to practically complete loss of local anaesthetic 
properties and that is why such modification should be considered unsuccessful. In other 
words, there is no reason to declare 4-hydroxy-2-oxo-1,2-dihydroquinoline and 4-hydroxy-
2-oxo-1,2,5,6,7,8-hexahydroquinoline molecular systems to be bioisosteric (at least, in 
relation to local anaesthesia). 
5.2 1-R-3-(2-Diethylaminoethyl)-1H-quinazoline-2,4-diones hydrochlorides 
All ways of modification of Chinoxicaine molecule considered by us previously could not 
remove the local irritant action completely, therefore, it can be assumed that this drawback 
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had been stipulated mainly by the presence of 4-Ǽǻ-group. Thus, the next step of 
potentially bioisosteric transformation of Chinoxicaine was the synthesis of compounds 
known to be without groupings with acid properties. One of the examples of such 
substances were 1-R-3-(2-diethylaminoethyl)-1H-quinazoline-2,4-diones hydrochlorides 15a-f 
(Figure 7). We considered various variants of obtaining compounds of this class allowing to 
choose the most suitable of them depending on the structure of the target product 
(Ukrainets et al., 2010) 
 
N
N
O
O
N
R
Et
Et . HCl
15: a R = H;  b R = Me; c R = Et; d R = Pr; e R = Bu; f R = i-Bu  
Fig. 7. Derivatives of 1H-quinazoline-2,4-dione 
The study of the local irritant action of 1-R-3-(2-diethylaminoethyl)-1H-quinazoline-2,4-
diones hydrochlorides 15 conducted in rabbits by the method of Lebo and Camage, has 
shown that the substances under research in the form of aqueous solutions with 2% 
concentration do not cause any reactive changes on the surface of the skin of the 
experimental animals. It should be worth mentioning that in similar conditions 
Chinoxicaine also does not reveal the irritating effect. That is why other, more sensitive, 
models should be involved in further research. 
The ability of 2% aqueous solutions of the compounds synthesized to cause infiltration 
anaesthesia of the skin and subcutaneous cellulose has been studied in guinea pigs 
(Buelbring-Yueid method). Simultaneously several parameters characterizing the basic 
specific manifestations of the pharmacological effect such as the rate of anaesthesia onset, its 
depth (potency) and duration were taken into account. The data given in Table 2 shows that 
all 1-R-3-(2-diethylaminoethyl)-1H-quinazoline-2,4-diones hydrochlorides 15, without 
exception, possess the local anaesthetic properties in some degree. In most cases anaesthesia 
occurs rather quickly and in some minutes after injection, the phase of deep anaesthesia 
begins. However, in spite of high values of the infiltration anaesthesia index, sometimes 
reaching the duration of the total anaesthesia caused by quinazolones 15 remains 
comparatively short and they yield to Chinoxicaine and Lidocaine greatly by this parameter.  
However, unlike the reference drugs the most active of the compounds synthesized – 
hydrochlorides 15a,e,f – reveal a number of new properties, which can be considered as 
useful in the complex of the short, but powerful local anaesthetic action. They are sedation 
as well as movement disorder or motor block on the site of introduction of the substance 
examined. The motor block was estimated on the "peak" of the local anesthesia by 5 point 
scale: 0 points - the tail root tone preserved, movements preserved in full; 1 point - 
weakening of the tail root tone; 2 points - the weak tail root tone, sluggish movement, the 
animal sitting more; 3 points - lowering of the tail root tone and possible slight movement of 
the animal during stimulation of the skin section not occurring in the anesthetized zone, 
slight inhibition of the animal; 4 points - general atonia of the tail root, appearance of some 
inhibition of movement in response to stimulation, overall inhibition of the animal; 5 points 
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- the state of general atonia of the tail root without movement upon pain or electrical 
stimulation of the skin outside the area of anesthesia, the animal lying on side.  
 
Compound 
Infiltration anaesthesia 
Motor block, 
points 
Sedative 
effect,  
points 
The start of 
anaesthesia, 
min 
Index 
Duration of  
total  anaesthesia, 
min 
15a 1.14 ± 0.16 36.0 32.35 ± 1.38 4 1 
15b 1.53 ± 0.19 35.8 30.19 ± 0.75 0 0 
15c 4.46 ± 0.29 18.5 15.74 ± 1.05 0 1 
15d 2.97 ± 0.32 35.7 29.82 ± 0.59 0 0 
15e 2.82 ± 0.43 36.0 36.46 ± 2.53 5 1 
15f 1.59 ± 0.25 34.2 29.20 ± 1.43 5 3 
Chinoxicaine 1.50 ± 0.04 36.0 75.61 ± 4.54 0 0 
Lidocaine 2.12 ± 0.19 36.0 52.80 ± 3.76 0 0 
Table 2. Biological properties of the quinazoline-2,4-diones hydrochlorides  15 
The sedative effect was estimated in the following way: 0 points - absent, the animal moving 
independently in cage; 1 point - the animal calm, sitting more, moving around the cage only 
when disturbed by the researcher; 2 points - the animal slowed down, sitting in the corner of 
the cage, anxiety with the researcher significantly set aside and again sitting, often closing 
eyelids, sleep onset; 3 points - the animal sleeping, lying on side, not responsive to 
stimulation by the researcher or to needle stick. 
In general, the combination of analgesic, sedative and immobile extremities effects 
rendering by hydrochlorides 15a,e,f can be used in creating medicines on their basis that are 
available for practical application in tiny surgical interventions, for example, in veterinary 
medicine. Thus, it can be stated confidently that 1-R-quinazoline-2,4-dionic cycle is 
bioisoster of 4-hydroxy-2-oxo-1,2-dihydroquinoline nucleus. 
5.3 The irreversible chemical modification of Сhinoxicaine at position 4 of the 
quinolone nucleus 
The complex research described by us above has shown convincingly that 4-Ǽǻ-group is 
the main cause of the local irritant properties of Сhinoxicaine. Therefore, after its blocking 
one can expect the elimination of the undesired side effect. Meanwhile, we have not even 
considered alkylation or acylation of 4-Ǽǻ-group as the most obvious variant of another 
bioreversible modification of Сhinoxicaine. The reason is quite simple. Within a rather 
limited choice of pharmacologically available protective groups, neither 4-Ǽ-alkyl, nor 4-Ǽ-
acyl derivatives of 4-hydroxyquinolin-2-ones have a high chemical stability. It is the 
tendency to hydrolysis that is a serious obstacle when synthesizing such compounds, as 
well as when further preparing sterile solutions for injections on their basis. 
Taking it into account we tried to modify 4-Ǽǻ-group of Сhinoxicaine not by means of 
forming pro-drugs, but by using the same method of bioisosteric replacements, i.e. by its 
irreversible replacement with the groupings similar not by sizes or volume, but having the 
same physical and chemical properties and that is why inducing the similar 
pharmacological effect (King, 2002).  
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The first example of such transformation was 4-chloro-2-oxo-1-propyl-1,2-dihydroquinoline-
3-carboxylic acid (2-diethylaminoethyl)amide hydrochloride 16 (Figure 8). 
A high reactivity of the chlorine atom in 1-R-4-chloro-3-ethoxycarbonyl-2-oxo-1,2-dihydro-
quinolines in relation to nucleophilic reagents allows to transform them easily into 4-
methyl-2-oxo-1,2-dihydroquinoline-3-carboxylic acids, one being the basis for synthesis of 
one more bioisoster of Сhinoxicaine – 4-methyl substituted analogue 17. 
N-R-Amides of 2-oxo-1,2-dihydroquinoline-3-carboxylic acid with a primary amino group 
in position 4 of the quinolone ring exist in the 2-hydroxy-4-imino form rapidly hydrolyzed 
by mineral acids to 4-hydroxy-2-quinolones (Ukrainets et al., 2006b). Proceeding from it as 
the next object for pharmacological screening we deliberately obtained hydrochloride of 4-
diethylamino-2-oxo-1-propyl-1,2-dihydroquinoline-3-carboxylic acid (2-diethylaminoethyl)-
amide 18 as chemically more stable product. Amides 19a-d containing no substituents at 
position 4 are of particular interest, in spite of the fact that due to the absence of these 
substituents they cannot be considered to be classical bioisosters of Сhinoxicaine.  
The study of local irritant action of the compounds synthesized, the ability to cause 
infiltration anaesthesia of the skin and subcutaneous cellulose, as well as the evaluation of 
the motor block and the sedative effect were carried out by standard methods previously 
described in detail by us (Ukrainets et al., 2010). It has been determined that all substances 
tested in the form of aqueous solutions with 2% concentration do not cause any reactive 
changes on the skin surface of the experimental animals. 
From the data presented in Table 3 it follows that bioisosteric replacement of 4-Ǽǻ-group to 
the chlorine atom – amide 16 – leads to significant decrease of all pharmacological indexes 
and, therefore,  it is unsuccessful. 
 
N
R
O
Pr
N
H
O
N
Et
Et
N O
R
N
H
O
N
Et
Et
N
N
H
O
N
Et
Et
. HCl
16  R = Cl
17  R = Me
18  R = N(Et)2
. HCl
19: a R = Et; b R = Pr; c R = Bu; d R = i-Bu
. HCl
20
OBu-i
 
Fig. 8. Modification of  4-Ǽǻ-group of Сhinoxicaine 
More interesting was the replacement of the hydroxyl group to the methyl one. From all 
substances of the last series 4-methyl-substituted amide 17 possesses the most rapid 
development of the biological effect (less than 2 min after injection). The infiltration 
anaesthesia index reaches the maximum possible value, and the total anaesthesia or the time 
of absence of pain and all types of sensitivity (tactile, temperature, etc.), during which the 
surgical intervention can be made (the section of tissues, wound suture, etc.), last 
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approximately 55 min. These data prove the sufficient high activity of amide 17, which are 
comparable to the reference drugs - Chinoxicaine and Lidocaine. However, amide 17 yields 
them significantly in the total duration of anaesthesia, i.e. time when the sensitivity 
increases gradually and then restores  completely.  
 
Compound 
Infiltration anaesthesia 
Motor 
block, 
points 
Sedative 
effect,  
points 
The start of 
anaesthesia, 
min 
Index 
The total 
anaesthesia, 
min 
The general 
duration of  
anaesthesia, 
min 
16 3.96 ± 0.42 26.3 14.25 ± 1.11 24.72 ± 2.18 0 0 
17 1.94 ± 0.21 36.0 55.33 ± 2.74 68.38 ± 2.68 0 0 
18 2.28 ± 0.31 36.0 37.51 ± 2.83 67.85 ± 2.37 0 0 
19a 4.52 ± 0.32 19.3 13.20 ± 1.00 21.01 ± 1.67 0 0 
19b 4.50 ± 0.36 35.5 27.89 ± 1.89 32.34 ± 2.92 0 0 
19c 3.03 ± 0.28 36.0 39.04 ± 2.12 58.26 ± 2.81 5 2 
19d 2.71 ± 0.37 36.0 53.77 ± 1.93 83.28 ± 2.05 5 3 
20 2.82 ± 0.44 35.6 47.56 ± 1.74 85.48 ± 2.33 5 3 
Chinoxicaine 1.62 ± 0.13 36.0 74.74 ± 4.71 236.89 ± 9.34 0 0 
Lidocaine 2.34 ± 0.20 36.0 51.26 ± 3.45 140.27 ± 6.20 0 0 
Table 3. Biological properties of 4-Ǽǻ-modified derivatives of Chinoxicaine  
A special attention should be paid to 4-diethylamine derivative 18, not only for its high 
anaesthetic properties, but for the perspective to perform further modifications of such type 
easily and practically in unlimited quantity as well and to reach the result required. 
From the series of non-substituted amides 19 at position 4 it is worth mentioning only 
compounds with butyl and iso-butyl substituents at the cyclic nitrogen atom (amides 19c 
and 19d respectively). Both are characterized by a rather rapid onset of action and high 
values of infiltration anaesthesia indexes. The distinctive feature of the first one is the signs 
of drowsiness, inertia in animals in 10-15 min after the injection and complete sleepiness can 
occur at 15-20 min. The motor block with the strength of 5 points lasts for approximately 20 
min on the site of introduction of the substance examined. In the case of amide 19d already 
by 7-10 min after injection the animals had the state of deep sleep: they slept on their side 
without the reaction to the active stimulation by the needle (tactile, pain and temperature 
sensitivity is absent). In 15-20 min the animals awoke, but they were drowsy and motionless 
for approximately 20 min and then began to move their paws. Therefore, one can speak 
about the deep and prolonged motor block and the marked sedative effect, which can be 
very useful properties of local anesthetic while conducting a number of short-termed 
surgical interventions, especially when rendering aid to patients with the increased 
excitability and possible fear before any surgical manipulations. 
The study of hydrochloride of 2-isobutoxyquinoline-3-carboxylic acid (2-diethylamino-
ethyl)amide 20 is of particular interest. This compound has been specially synthesized by us 
as an aromatic analogue of the most active of 1,2-dihydro derivatives, i.e. amide 19d. A 
comparative analysis of biological properties of these isomers demonstrates that with 
transfer to the aromatic structure some parameters decrease, and others, vice versa, 
intensify. For example, amide 20 differs with the later start of anaesthesia, decrease of the 
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index and reduction of duration of the deep anaesthesia phase. At the same time the general 
duration of anaesthesia increases a little, as well as duration of the sedative effect. 
Unfortunately, transfer of the isobutyl substituent from the nitrogen atom to the oxygen 
atom is accompanied by appearance of undesirable properties – unlike amide 19d its 
aromatic isomer 20 has been found to have the irritant action, though a transient one.  
6. Conclusion 
The research carried out by us gives reason to suppose that 4-hydroxy-2-oxo-1,2-dihydro-
quinoline-3-carboxylic acids are of great interest as a base in creating new effective 
medicines to eliminate pain. Such medicines can be not only local anesthetics possessing the 
unique complex of pharmacological properties, but, as it has been found quite recently, non-
narcotic analgesics with high activity and low toxicity as well. The rich arsenal of  structural 
and biological regularities accumulated, as well as practically unlimited synthetic potential 
of 4-hydroxyquinolin-2-ones allow to change the character of impact of such compounds on 
a living organism easily and in the required direction, and thus, to provide their direct 
practical value and a great perspective. 
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treatment. Several chapters report original research, while others summarize clinical information with specific
treatment options. The international mix of authors reflects the "casting of a broad net" to recruit authors on
the cutting edge of their area of interest. Pain Management - Current Issues and Opinions is a must read for
the up-to-date pain clinician.
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